Avestar Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,635
| Closed | -$682K | – | 437 |
|
|
2023
Q4 | $682K | Sell |
7,635
-70
| -0.9% | -$6.25K | 0.08% | 143 |
|
|
2023
Q3 | $563K | Buy |
7,705
+100
| +1% | +$7.3K | 0.08% | 143 |
|
|
2023
Q2 | $633K | Sell |
7,605
-500
| -6% | -$41.6K | 0.1% | 112 |
|
|
2023
Q1 | $618K | Sell |
8,105
-265
| -3% | -$20.2K | 0.11% | 111 |
|
|
2022
Q4 | $695K | Sell |
8,370
-50
| -0.6% | -$4.15K | 0.13% | 98 |
|
|
2022
Q3 | $668K | Buy |
8,420
+200
| +2% | +$15.9K | 0.17% | 79 |
|
|
2022
Q2 | $610K | Buy |
+8,220
| New | +$610K | 0.15% | 87 |
|
|
2018
Q4 | – | Sell |
-19,505
| Closed | -$1.85M | – | 1021 |
|
|
2018
Q3 | $1.85M | Buy |
19,505
+4,255
| +28% | +$403K | 1.07% | 24 |
|
|
2018
Q2 | $1.43M | Buy |
15,250
+5,810
| +62% | +$546K | 0.91% | 27 |
|
|
2018
Q1 | $813K | Buy |
9,440
+2,571
| +37% | +$221K | 0.53% | 36 |
|
|
2017
Q4 | $578K | Buy |
+6,869
| New | +$578K | 0.43% | 35 |
|